United States · FDA National Drug Code directory

Novo Nordisk Pharma, Inc.

Labeler · 8 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 73070-100_18e1bdfe-0180-4988-9797-5ee4660e3840

Insulin Aspart

INJECTION, SOLUTION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-102_18e1bdfe-0180-4988-9797-5ee4660e3840

Insulin Aspart

INJECTION, SOLUTION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-103_18e1bdfe-0180-4988-9797-5ee4660e3840

Insulin Aspart

INJECTION, SOLUTION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-200_885b9016-188e-469d-926d-ae8019b69612

Insulin Aspart Protamine and Insulin Aspart Mix 70/30

INJECTION, SUSPENSION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-203_885b9016-188e-469d-926d-ae8019b69612

Insulin Aspart Protamine and Insulin Aspart Mix 70/30

INJECTION, SUSPENSION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-400_6bb8d7a1-4fd3-4c63-8a88-910bbcb3f1ad

Insulin Degludec

INJECTION, SOLUTION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-403_6bb8d7a1-4fd3-4c63-8a88-910bbcb3f1ad

Insulin Degludec

INJECTION, SOLUTION / Novo Nordisk Pharma, Inc.

United States · Source reference 73070-503_6bb8d7a1-4fd3-4c63-8a88-910bbcb3f1ad

Insulin Degludec

INJECTION, SOLUTION / Novo Nordisk Pharma, Inc.

Browse companies in United States →